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Abstract
Biodegradable polymers have been used in implantable medical devices, such as suture fibers,
fixation screws and soft tissue engineering devices. Apart from biological compatibility, these
devices shall also be functional compatible and perform adequate mechanical temporary support
during the healing process. In regenerative medicine, the scaffold that will provide this temporary
support should simultaneously enhance cellular adhesion, proliferation and remodeling of new
tissue. In soft tissue applications, biodegradable polymers are the materials of election. These
materials undergo through a process of degradation, mainly controlled by hydrolysis, leading to
a reduction of molecular weight, followed by reduction of strength and finally a reduction of mass
until it is totally absorbed and assimilated by the host. Fatigue/creep damage also contribute to
the progressive decrease of mechanical properties. Meanwhile, cells cultured over the scaffold will
produce the new tissue that will gradually replace the material biomechanical functions.
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Resumo
Os polímeros biodegradáveis têm sido utilizados em dispositivos médicos implantáveis, como
fios de sutura, parafusos e dispositivos para engenharia de tecidos moles. Além da compatibilidade
biológica, tais dispositivos devem apresentar compatibilidade funcional e desempenhar funções
temporárias de suporte mecânico durante o processo de cura. Em medicina regenerativa, este
suporte temporário deve favorecer a adesão celular, a sua proliferação e a remodelação de novo
tecido. Em engenharia de tecidos moles os polímeros biodegradáveis são os materiais de eleição.
Estes materiais sofrem um processo de degradação, controlado sobretudo hidrólise, e que resulta
numa redução do peso molecular, seguida de uma redução da resistência mecânica e finalmente
uma redução da massa até a completa absorção e assimilação pelo organismo. O dano por fadiga/
fluência também contribui para a progressiva diminuição das propriedades mecânicas. Entretanto,
as células cultivadas sobre o suporte vão produzir o novo tecido que vai gradualmente substituir
as funções biomecânicas do material.
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8Introduction
In reconstructive medicine, traditional materials
have been used to make implant devices able to
replace the biological functions of a tissue.
Polyurethane (PU), poly(tetrafluoroethylene)
(PTFE), Polyetheretherketone (PEEK),
polyethylene (PE) have been used in soft tissue
devices due to there biocompatibility. Examples of
these are vascular or valvular devices, ligament
tissues augmentation devices, etc. These materials
are considered bioinert and they don’t evoke any
deleterious biologic response. However, at later time
points, biomedical devices are prone to fatigue
rupture or laxity due to creep, resulting in long term
inefficiency. This usually implies revision surgeries,
onerous for the patient and for the health care
system.
New concepts of regenerative medicine are
based on cells seeded over scaffolds, that can
temporary replace the biomechanical functions, and
will progressively be replaced by the new tissue
formed.  Scaffolds, cells and the environment
(physical and chemical) constitute the three major
components in regenerative medicine, and
successful engineering of any tissue requires that
the various components be optimized.
Such scaffolds should possess an optimized
architecture that provides favourable porosity and
surface area to allow the seeded cells to proliferate
and regenerate the tissue. A minimum pore diameter
of 200-250  m is suggested for soft tissue ingrowth
[1]. The presence of pore interconnectivity
extending through an implant increases the overall
surface area for cell attachment, which in turn can
enhance the regenerative properties of the implant
by allowing tissue ingrowth into the interior of the
scaffold [2]. Overall scaffold porosity can modulate
gross cellular response to the implant but also their
biomechanical behaviour.
A successful tissue engineered scaffold must
display similar mechanical behavior (shape of the
stress–strain and stress relaxation response), have
endurance strength (fatigue resistance at the same
frequency of the application) have mechanical
properties that are similar to or greater than the
tissue it is regenerating, promote tissue ingrowth,
and degrade at a rate that does not cause stress
shielding or rupture of the new tissue. In the design
and optimization process, damage simulation due
to hydrolysis and fatigue/creep is a helpful tool in
predicting outcomes and to analyze functional
compatibility. To be biocompatible and ensure final
clinical use, neither the scaffold nor its degradation
products should be harmful to the surrounding tissue
and they should not result in unresolved
inflammation.
Materials
The most popular and important biodegradable
polymers are aliphatic polyesters, such as polylactic
acid (PLA), polyglycolic acid (PGA),
polycaprolactone (PCL), polydioxone (PDO),
polyhydoxyalkanoates (PHA’s), polyethylene oxide
(PEO), poly(propylene succinate) (PPSu), poly
(butylene succinate) (PBSu),  poly(ethylene
succinate) (PESu), poly(butylene succinate-co-
butylene adipate) (PBSA), etc. Processing
technologies of these materials are the same of
traditional thermoplastic polymers. In table 1, the
chemical structures of the common aliphatic
polyesters are presented (Table 1).
Aliphatic polyesters are a central class of
biodegradable thermoplastic polymers, because
hydrolytic and/or enzymatic chain cleavage of these
materials leads to   -hydroxyacids, which in most
cases are ultimately metabolized. For soft tissue
applications, depending on material selection, a large
range of mechanical properties are possible
(Figure1).
Synthetic biodegradable PLA, PGA, and
copolymers of these, have been manufactured for
biomedical applications since the 1970s. Since then,
FDA has approved its use for a variety of clinical
applications, [3-7], e.g. for surgical sutures [8, 9],
internal bone fixation [10] and drug delivery systems
[11], because they present good biodegradability,
biocompatibility, reasonably good mechanical
properties and processibility. They have also been
investigated for use in tissue engineering and
regenerative medicine. Since they display different
degradation rates, their combination enables to
regulate the degradation time.
Polycaprolactone is also an important member
of the aliphatic polyester family [12], suitable for
long-term use in implants presenting a slower
degradation rate than those of PLLA and PGA [13].
Due to its low stiffness, it is commonly combined
with PLA to decrease its brittle behavior in slow
degrading devices.
Hydrophilic materials are more prone to swell,
corresponding to a greater decrease of the
mechanical properties. By presenting higher
saturation level they degrade faster, since
degradation time is proportional to water
concentration. That is the case of hydrophilic PGA
compared to PLA. Poly(ethylene glycol) PEG is
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9Table 1. Chemical structures of the common aliphatic polyesters.
Figure 1. Range of stiffness vs degradation time of aliphatic polyesters.
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another hydrophilic, water soluble and fully
biodegradable polymer. PEG’s lack of toxicity allows
its usage in many biomedical and pharmaceutical
applications [14, 15].
PHA’s, particularly poly 3-hydroxybutyrate
(PHB), copolymers of 3-hydroxybutyrate and 3-
hydroxyvalerate (PHBV), poly 4-hydroxybutyrate
(P4HB), copolymers of 3-hydroxybutyrate and 3-
hydroxyhexanoate (PHBHHx) and poly 3-
hydroxyoctanoate (PHO) and its composites have
been used to develop a great variety of
biodegradable devices [16] with a large range of
degradation times and mechanical properties.
However, each of these alone may have some
shortcomings which restrict its applications, due to
inappropriate stiffness, strength or degradation rate.
It is possible to tune the hydrolytic rate constant of
the material, and also its final mechanical properties,
by block copolymerization or blending with other
biodegradable polymers, having different hydrolytic
rate constants. Copolymers of several lactides or
lactones can be synthesized by ring opening
polymerization resulting in high molecular weight
polyesters [17]. The mixture of different polymers
to produce blends, with controlled hydrolytic rate
and mechanical properties can be preformed in two
ways: mixing the melted polymers, or mixing
polymers solutions using a common solvent. The
miscibility is limited depending on polymers used
and their volume fractions. A composite solution of
several materials with different degradation rates
also enables tuning the rate of degradation of the
scaffold.
Hydrolytic Degradation
The degradation process of biopolymers is
composed of a sequence of reactions, mainly
diffusion of water and/or enzymes, and then
hydrolysis. The overall rate is determined by the
slowest reaction, named the rate-limiting step [18].
In the particular case of biodegradable polymers,
the penetrating water rapidly creates a negative
gradient of water concentrations from the surface
to the centre. Since water diffusion is very fast
compared to hydrolysis, one can consider that
hydrolysis of ester bonds starts homogeneously.
The water concentration (W) is determined using
Fick’s equation, presented for 1D [19]:
(1)
were the diffusion rate d can be determined by
measuring moisture absorption increased weight
during incubation.  The amount of absorbed water
is deduced from:
(2)
where Ws, and Wr, are the weight of the swollen
specimen (after wiping the surface with paper) and
the weight when dry, respectively. The swelling has
a major significance on the visco-elastic properties
of the material. When saturated, its ductile/fragile
transition will occur at higher strain rates.
The macromolecular skeleton of many polymers
is comprised of ester groups. These groups can go
through hydrolysis leading to chain scissions.
Hydrolysis has traditionally been modeled using a
first order kinetics based on the kinetic mechanism
of hydrolysis, according to the Michaelis–Menten
scheme [20]. In the ideal case of hydrolytic
degradation the following first-order equation
describes the hydrolytic process to occur relative
to the ester concentration (E) and water
concentration (W):
(3)
um is the medium hydrolysis rate of the material,
and W is constant as water is spread out uniformly
in the sample volume (no diffusion control). In this
ideal case, the hydrolysis rate constant, k, depends
only on temperature and does not vary with the
conversion (no autocatalysis).
Using the molecular weight, and since the
concentrations of carboxyl end groups
tn
ME /1= ;
the equation 3 turn:
(4)
where 
tn
M  and
0n
M , are the number-average
molecular weight, at a given time t and initially at
t=0, respectively.
Or using the scission number nt per mass unit,
as in [20], at time t is given, and the initial ester
concentration E0, the equation 3 becomes:
(5)
The experimental measurement of molecular
weights by SEC (Size Exclusion Chromatography)
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or GPC (Gel Permeation Chromatography) allows
the determination of nt.
(6)
These equations lead to a relationship Mn =f(t).
However, in the design phase of a biomedical device,
it is important to predict the evolution of mechanical
properties like stiffness and tensile strength, instead
of molecular weight. It has been shown [21] that
the fracture strength of a polymer can, in many
cases, be related to Mn through the relationship:
(7)
where σ is the fracture strength, σ
 
 is the
fracture strength at infinite molecular weight, and
B is a constant.
As this is an empirical equation, the constant B
must be determined for each material. One can
thus determine the limit strength for the device that
weakens during the tissue recovering, σd= f(t). The
variation of the tensile strength along with
degradation time is presented in figure 2, changing
with initial molecular weight. According to Farrar
and Gilson [22] the rate constant depends on the
structure of the polymer, and is independent of its
molecular weight (Figure 2).
In order to perform computer simulation based
on these models, the parameters diffusion
coefficient (d) and degradation rate constant (k)
must be previously determined by inverse
parameterization, on specimens of two different
thicknesses. For thin devices damage model can
be simplified assuming homogeneous hydrolysis.
On that ground, the mixture law may be used to
determine the hydrolysis rate of composite uc of n
degradable materials combined:
(8)
Mechanical properties of polymeric materials,
mainly thermoplastics, and also natural tissues,
highly depend on the strain rate applied to the
specimen. As the strain rate increase, there is a
transition from ductile to fragile behaviour. Material
tensile properties must so be determined at the same
strain rate. A general consequence of hydrolytic
process is the lowering of the plastic flow ability of
the polymer, thus causing the change from ductile
behavior into a brittle one or, if the behavior was
initially brittle, an increase in the brittleness.
Moreover, after hydrolysis started, brittleness may
occur at lower strain rates.
The degradation rate and the mechanical
properties of biodegradable polymers are also
strongly influenced by its morphology and
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Figure 2. Tensile strength vs time for different initial molecular weight [22].
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crystallinity. Generally, the biodegradation occurs
first in the lower crystalline regions. There are
numerous variables, such as the material’s chemical
structure, crystallinity, molecular weight, processing
conditions, shape and size, affecting the polymer
degradation mechanisms.
Damage Modeling
The extent of distributed damage in a material
can be characterized as Wang et al. [23] for
polycarbonate, by a measurable macroscopic
parameter, such as the residual fracture strain.
Damage variable, including fatigue/creep and
degradation, can be defined as:
(9)
where fε  is the fracture strain for a virgin
sample, and fε~ is the residual fracture strain after
damage occurs by creep/fatigue and biodegradation.
Damage is a time dependent variable that can
be added to the stiffness, including fatigue and
hydrolytic degradation along time. This simple
analytical model allows the simulation of tissue
stiffness during its degradation. The resulting
stiffness must be compatible to natural tissue
stiffness recovering. Having determined the
molecular weight and the mechanical properties at
the nth discrete time point, the damage equation due
to hydrolysis and fatigue can be solved and it can
be proceed to the next time step.
In homogeneous hydrolysis conditions we
defined damage due to hydrolysis as:
(10)
where  is the fracture strength  for a virgin
sample, and is the residual fracture strength
after hydrolytic damage occurs.
Continuum damage mechanics (CDM) are
widely used for the determination of material failure
under creep, fatigue and particularly creep–fatigue-
interacted processes [24-26]. As the temperature
increases, and minimum stress become significant
the interaction between the processes of creep and
fatigue can lead to significant reductions in product
life, due to early rupture or excessive laxity. Unified
constitutive models in terms of internal variables
representing the damage caused by creep and
fatigue, and the damage caused by their interaction,
have thus been proposed [25, 27, 28]. After a
polymeric structure is subjected to a certain number
of loading cycles, damage such as shear bands,
micro-crazes, micro-cracks, macroscopic crazes
and cracks may be formed. This damage can also
reduce the material integrity, leading to a residual
fracture strain that is lower than that for a perfect
virgin structure.
The fatigue damage, Df, evolution per cycle can
be expressed as [23]:
(11)
where s0 and S0 are the material characteristic
constants.
Assuming that the damage variable Df is zero at
the beginning of the cyclic loading, that is, when
N=0, Df=0. Then the damage value at any cycle,
due exclusively to fatigue, can be determined by
integrating Eq. (11),
 (12)
Thus, the relation between the damage variable
Df and the number of cycles N is:
(13)
The fatigue life Nf can be represented by:
(14)
Eq. (14) can be readily used to predict the fatigue
life, and this equation can also be expressed in the
following form [23]:
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(15)
where
(16)
Young’s modulus E and fracture strain εf can
be determined from material tests at the same strain
rate of the application. The stress amplitude ∆σ
versus fatigue life Nf curve can be obtained by
fatigue tests for polymers, at the same frequency
of the application. Thus coefficients A and B can
be determined through this curve. Finally s0 and S0
can be calculated by Eq. (16). The fatigue damage
evolution equation can be obtained as [23]:
(17)
Conclusions
In the conception of a tissue-engineered device,
both functional and biological compatibility should
be attended. In this review paper, a generic
approach towards the biomechanical requirements
is presented. This approach may obviate many of
the shortcomings of current techniques.
The material selection and dimensioning of a
biodegradable structure, able to deform with the
convalescent tissue avoiding its stress shielding, able
to support dynamic tensile loads, without excessive
laxity associated to material creep, and able to
degrade being gradually substituted by natural tissue
during the process, has a major influence on optimal
healing. The dimensioning method proposed here
is an iterative process based on a damage model
that includes fatigue and enzymatic hydrolysis. This
model allows the simulation of the mechanical
properties evolution during biodegradation. Material
conditions like temperature, loading conditions and
surrounding environment must be considered on the
dimensioning and validation.
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